Omnic (Tamsulosin Hydrochloride)

Tamsulosin Hydrochloride, the active ingredient in Omnic, is an Alpha‑1 adrenergic receptor antagonist (alpha‑blocker) presented as a 0.4 mg tablet for oral use. It is used to improve urinary flow in men with benign prostatic hyperplasia. GNH USA supplies Omnic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omnic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tamsulosin Hydrochloride is used in urological conditions that involve smooth‑muscle tone in the prostate and bladder neck.

- Benign prostatic hyperplasia (BPH): relieves urinary obstruction and improves urine flow. - Chronic prostatitis: may reduce urinary symptoms associated with prostatitis. - Pre‑surgical preparation for transurethral resection of the prostate (TUR‑P): helps reduce intra‑operative bleeding by relaxing prostatic smooth muscle.

Tamsulosin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness or light‑headedness, especially on standing. - Abnormal ejaculation, such as reduced volume or retrograde flow. - Nasal congestion or runny nose. - Headache. - Fatigue.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Priapism (prolonged erection). - Allergic reactions including rash, itching, or swelling. - Angio‑edema affecting face or throat. - Acute urinary retention.

Patients should be counseled on safety considerations before starting tamsulosin therapy.

- Orthostatic hypotension: rise slowly from sitting or lying positions. - Cardiovascular disease: monitor blood pressure and heart rate. - Liver impairment: use with caution; dose adjustment may be needed. - Drug interactions: review concomitant medications for potential additive hypotensive effects. - Surgery: inform surgeons of tamsulosin use prior to procedures involving spinal or epidural anesthesia. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Tamsuloset may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): increased risk of profound hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise plasma tamsulosin levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (e.g., ACE inhibitors, diuretics): additive blood‑pressure‑lowering effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance orthostatic hypotension. - Beta‑blockers: combined effect on heart rate and blood pressure.